- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有64家主力机构披露2026-06-30报告期持股数据，持仓量总计1.93亿股，占流通A股44.20%
- 波段诊断：
-
技术面诊股
诊断结果：4.5技术面打败了35%的股票
技术面评分前10的股票
近期的平均成本为7.62元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为7.62元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"7.62","date":1788337583,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2026.09.03","stock":"-0.92","trade":null,"ind":"0.02"},{"date":"2026.09.02","stock":"-0.78","trade":null,"ind":"-0.97"},{"date":"2026.09.01","stock":"1.72","trade":null,"ind":"-0.16"},{"date":"2026.08.31","stock":"-0.66","trade":null,"ind":"0.86"},{"date":"2026.08.28","stock":"1.06","trade":null,"ind":"-0.11"},{"date":"2026.08.27","stock":"-0.13","trade":null,"ind":"1.13"},{"date":"2026.08.26","stock":"0.27","trade":null,"ind":"0.59"},{"date":"2026.08.25","stock":"0.94","trade":null,"ind":"0.19"},{"date":"2026.08.24","stock":"-0.27","trade":null,"ind":"-0.59"},{"date":"2026.08.21","stock":"-2.86","trade":null,"ind":"0.04"},{"date":"2026.08.20","stock":"3.22","trade":null,"ind":"0.24"},{"date":"2026.08.19","stock":"-1.71","trade":null,"ind":"-2.40"},{"date":"2026.08.18","stock":"-0.13","trade":null,"ind":"0.19"},{"date":"2026.08.17","stock":"-0.65","trade":null,"ind":"1.41"},{"date":"2026.08.14","stock":"0.26","trade":null,"ind":"0.01"},{"date":"2026.08.13","stock":"0.39","trade":null,"ind":"-0.50"},{"date":"2026.08.12","stock":"0.13","trade":null,"ind":"0.32"},{"date":"2026.08.11","stock":"-0.78","trade":null,"ind":"-0.82"},{"date":"2026.08.10","stock":"3.10","trade":null,"ind":"0.67"},{"date":"2026.08.07","stock":"1.37","trade":null,"ind":"1.02"},{"date":"2026.08.06","stock":"-0.41","trade":null,"ind":"0.57"}]
康德莱,上证指数,医疗器械指数
压力支撑
该股压力位为7.61元，支撑位为7.53元。
[{"text":"\u538b\u529b\u4f4d","value":"7.61","date":1788364800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"7.53","date":1788364800,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.4资金面打败了53%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：09月03日 20:32
| 机构今日流向(万元) | -536.72 | 机构5日流向(万元) | -2279.43 |
| 机构10日流向(万元) | -4531.86 | 机构20日流向(万元) | -7134.80 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少520.37万股，其中基金净减仓5家，主力净减仓21家，请投资者中长期谨慎为宜。
截止2026-06-30，共64家主力机构（基金60家，一般法人3家，保险公司1家），持仓量总计19307.01万股，占流通A股44.20%
其中，基金持仓与2025-12-31相比：
增仓：13家 ，增持 25.14万股
减仓：18家 ，减持 68.73万股
新出现在主力名单中：25家 ，持有136.5万股
从主力名单中消失：46家 ，原持有767.09万股
其中，基金持仓与2025-12-31相比：
增仓：13家 ，增持 25.14万股
减仓：18家 ，减持 68.73万股
新出现在主力名单中：25家 ，持有136.5万股
从主力名单中消失：46家 ，原持有767.09万股
消息面诊股
诊断结果：5.6消息面打败了63%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 康德莱：公司应收账款主要因医院等医疗机构的回款周期
2026-09-01 - 股东追踪|郑巨灿等新进康德莱前十大流通股东
2026-08-26 - 康德莱（截止2026年6月30日）股东人数为250
2026-08-25 - 康德莱：2026年上半年净利润1.12亿元，同比下
2026-08-25 - 研判2026！中国血细胞分离机行业相关政策、市场规
2026-08-19 - 康德莱：大股东增持需要严格遵守上市公司监管规则，窗
2026-08-10 - 康德莱2026年半年度目标经营会议召开
2026-07-24 - 研判2026！中国胰岛素行业分类、市场规模、进出口
2026-07-14 - 康德莱：公司秉承低成本经营理念，将提质增效作为工作
2026-06-29 - 沪市主板回购增持持续升温 龙头公司大手笔“护盘”显
2026-06-22
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-26 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2026-06-30 |
| 一般消息 | 重大事项 | 关联交易 | 2026-06-11 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-05-26 |
| 利好 | 分红转增 | 10派1.70元(含税) | 2026-04-21 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-13 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-10-23 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了10%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.09.03","price":"0.02","value":null},{"date":"2026.09.02","price":"-0.97","value":null},{"date":"2026.09.01","price":"-0.16","value":null},{"date":"2026.08.31","price":"0.86","value":null},{"date":"2026.08.28","price":"-0.11","value":null},{"date":"2026.08.27","price":"1.13","value":null},{"date":"2026.08.26","price":"0.59","value":null},{"date":"2026.08.25","price":"0.19","value":null},{"date":"2026.08.24","price":"-0.59","value":null},{"date":"2026.08.21","price":"0.04","value":null},{"date":"2026.08.20","price":"0.24","value":null},{"date":"2026.08.19","price":"-2.40","value":null},{"date":"2026.08.18","price":"0.19","value":null},{"date":"2026.08.17","price":"1.41","value":null},{"date":"2026.08.14","price":"0.01","value":null},{"date":"2026.08.13","price":"-0.50","value":null},{"date":"2026.08.12","price":"0.32","value":null},{"date":"2026.08.11","price":"-0.82","value":null},{"date":"2026.08.10","price":"0.67","value":null},{"date":"2026.08.07","price":"1.02","value":null},{"date":"2026.08.06","price":"0.57","value":"-357279036.44"}]
上证指数,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 五洲医疗 | 50.49% | -0.85% | 4.5分 |
| 2 | 透景生命 | 42.87% | 6.26% | 5.1分 |
| 3 | 采纳股份 | 42.86% | 14.93% | 5.9分 |
| 4 | 南卫股份 | 36.33% | 6.93% | 4.6分 |
| 5 | 洁特生物 | 36.33% | 33.80% | 4.7分 |
| 6 | 乐心医疗 | 22.86% | 8.98% | 5.8分 |
| 8 | 海泰新光 | 20.73% | -2.47% | 4.8分 |
| 10 | 华大智造 | 17.87% | -15.35% | 4.4分 |
| 12 | 惠泰医疗 | 16.37% | -2.61% | 4.8分 |
| 14 | 戴维医疗 | 15.88% | -5.61% | 4.2分 |
| 16 | 澳华内镜 | 15.60% | 9.12% | 5.5分 |
| 18 | 英科医疗 | 12.24% | -0.30% | 5.4分 |
| 20 | 亚辉龙 | 11.32% | -5.86% | 4.8分 |
| 22 | 科华生物 | 9.96% | 0.35% | 5.1分 |
| 24 | 南微医学 | 9.53% | 2.53% | 5.9分 |
| 26 | 海尔生物 | 8.73% | -1.16% | 5.2分 |
| 28 | 爱威科技 | 8.30% | 1.92% | 4.8分 |
| 30 | 奥精医疗 | 7.99% | 3.45% | 4.1分 |
| 32 | 美康生物 | 7.36% | -0.74% | 4.9分 |
| 34 | 黄山胶囊 | 6.85% | -0.30% | 4.9分 |
| 36 | 港通医疗 | 5.55% | -2.59% | 4.6分 |
| 38 | - | 4.66% | 6.09% | 分 |
| 40 | 东星医疗 | 4.30% | -0.98% | 4.0分 |
| 42 | - | 3.86% | 2.38% | 分 |
| 44 | 健信超导 | 3.77% | -1.01% | 4.9分 |
| 46 | - | 3.66% | 0.53% | 分 |
| 48 | 康德莱 | 3.42% | 0.40% | 4.5分 |
| 50 | 九强生物 | 3.08% | 0.95% | 5.0分 |
| 52 | 爱迪特 | 2.85% | -3.08% | 4.9分 |
| 54 | 利德曼 | 2.62% | -4.55% | 3.7分 |
| 56 | 安旭生物 | 2.50% | -1.19% | 3.9分 |
| 58 | 蓝帆医疗 | 2.21% | -1.96% | 5.8分 |
| 60 | ST迪瑞 | 1.85% | -1.24% | 4.6分 |
| 62 | 天益医疗 | 1.74% | 1.44% | 4.7分 |
| 64 | 冠昊生物 | 1.67% | -3.18% | 4.4分 |
| 66 | ST凯利 | 1.46% | 1.79% | 4.8分 |
| 68 | 奥泰生物 | 1.27% | -4.00% | 4.0分 |
| 70 | - | 1.17% | 0.45% | 分 |
| 72 | 威高骨科 | 0.84% | -1.63% | 4.7分 |
| 74 | - | 0.68% | 3.04% | 分 |
| 76 | 东方生物 | -0.68% | -3.47% | 4.0分 |
| 78 | - | -0.76% | 2.99% | 分 |
| 80 | 仁度生物 | -0.86% | 0.46% | 3.8分 |
| 82 | 山东药玻 | -1.29% | -0.16% | 5.0分 |
| 84 | 三鑫医疗 | -1.59% | -4.63% | 5.2分 |
| 86 | 祥生医疗 | -1.84% | -0.21% | 5.1分 |
| 88 | 易瑞生物 | -2.39% | -4.39% | 4.3分 |
| 90 | 维力医疗 | -2.59% | -1.05% | 4.8分 |
| 92 | 三诺生物 | -2.72% | -2.54% | 5.2分 |
| 94 | *ST益通 | -2.74% | 4.76% | 4.4分 |
| 96 | 硕世生物 | -2.78% | -4.50% | 4.1分 |
| 98 | 麦克奥迪 | -3.01% | -2.86% | 4.8分 |
| 100 | 昊海生科 | -3.18% | -0.40% | 4.6分 |
| 102 | 济民健康 | -3.38% | 0.73% | 5.1分 |
| 104 | 鱼跃医疗 | -3.50% | -1.19% | 5.0分 |
| 106 | 爱朋医疗 | -3.83% | -0.59% | 4.4分 |
| 108 | 理邦仪器 | -4.01% | -0.93% | 4.6分 |
| 110 | 万东医疗 | -4.17% | 0.55% | 4.5分 |
| 112 | 九安医疗 | -4.69% | -2.00% | 4.5分 |
| 114 | 联影医疗 | -5.33% | -0.19% | 4.8分 |
| 116 | 麦澜德 | -5.61% | -3.73% | 3.3分 |
| 118 | 楚天科技 | -6.44% | -8.28% | 4.0分 |
| 120 | 可孚医疗 | -6.82% | -5.12% | 5.3分 |
| 122 | 北芯生命 | -6.91% | -5.16% | 5.1分 |
| 124 | 华兰股份 | -7.12% | -11.51% | 3.2分 |
| 126 | 力诺药包 | -7.76% | -6.84% | 4.3分 |
| 128 | 康拓医疗 | -7.93% | -3.05% | 4.5分 |
| 130 | 山外山 | -9.03% | -7.01% | 4.4分 |
| 132 | 迈普医学 | -9.38% | -0.22% | 4.7分 |
| 134 | 康众医疗 | -10.27% | -2.20% | 3.5分 |
| 136 | 微电生理 | -10.57% | -13.90% | 3.5分 |
| 138 | 健帆生物 | -13.69% | -3.27% | 4.5分 |
| 140 | 天智航 | -14.53% | -4.63% | 3.8分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 40/245 ， 109/245。
[{"date":"2026-06-30","value":"4.05","vol":"2.35"},{"date":"2026-03-31","value":"1.94","vol":"1.12"},{"date":"2025-12-31","value":"9.15","vol":"2.37"},{"date":"2025-09-30","value":"7.43","vol":"3.06"},{"date":"2025-06-30","value":"4.87","vol":"2.40"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.05 | 1.94 | 9.15 | 7.43 | 4.87 |
| 行业(%) | 2.35 | 1.12 | 2.37 | 3.06 | 2.40 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"31.20","vol":"52.38"},{"date":"2026-03-31","value":"31.50","vol":"52.12"},{"date":"2025-12-31","value":"33.06","vol":"51.82"},{"date":"2025-09-30","value":"32.59","vol":"52.03"},{"date":"2025-06-30","value":"32.66","vol":"52.36"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
31.20 | 31.50 | 33.06 | 32.59 | 32.66 |
| 行业(%) | 52.38 | 52.12 | 51.82 | 52.03 | 52.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 91/245 ， 74/245。
[{"date":"2026-06-30","value":"-3.21","vol":"5.46"},{"date":"2026-03-31","value":"-2.08","vol":"5.59"},{"date":"2025-12-31","value":"1.63","vol":"1.01"},{"date":"2025-09-30","value":"0.95","vol":"0.11"},{"date":"2025-06-30","value":"0.17","vol":"-1.37"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-3.21 | -2.08 | 1.63 | 0.95 | 0.17 |
| 行业(%) | 5.46 | 5.59 | 1.01 | 0.11 | -1.37 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"-10.23","vol":"-24.55"},{"date":"2026-03-31","value":"-10.93","vol":"-20.93"},{"date":"2025-12-31","value":"11.62","vol":"-33.44"},{"date":"2025-09-30","value":"17.27","vol":"-15.21"},{"date":"2025-06-30","value":"18.94","vol":"-17.88"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-10.23 | -10.93 | 11.62 | 17.27 | 18.94 |
| 行业(%) | -24.55 | -20.93 | -33.44 | -15.21 | -17.88 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 19/245 ， 15/245。
[{"date":"2026-06-30","value":"0.26","vol":"0.17"},{"date":"2026-03-31","value":"0.13","vol":"0.08"},{"date":"2025-12-31","value":"0.55","vol":"0.35"},{"date":"2025-09-30","value":"0.41","vol":"0.25"},{"date":"2025-06-30","value":"0.27","vol":"0.17"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.26 | 0.13 | 0.55 | 0.41 | 0.27 |
| 行业(次) | 0.17 | 0.08 | 0.35 | 0.25 | 0.17 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"1.99","vol":"1.12"},{"date":"2026-03-31","value":"0.99","vol":"0.55"},{"date":"2025-12-31","value":"3.71","vol":"2.33"},{"date":"2025-09-30","value":"2.69","vol":"1.66"},{"date":"2025-06-30","value":"1.76","vol":"1.12"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.99 | 0.99 | 3.71 | 2.69 | 1.76 |
| 行业(次) | 1.12 | 0.55 | 2.33 | 1.66 | 1.12 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 44/245 ， 23/245。
[{"date":"2026-06-30","value":"25.24","vol":"14.81"},{"date":"2026-03-31","value":"-4.29","vol":"-0.33"},{"date":"2025-12-31","value":"36.87","vol":"32.14"},{"date":"2025-09-30","value":"20.27","vol":"14.86"},{"date":"2025-06-30","value":"15.13","vol":"15.69"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 25.24 | -4.29 | 36.87 | 20.27 | 15.13 |
| 行业 | 14.81 | -0.33 | 32.14 | 14.86 | 15.69 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.34","vol":"1.31"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.92","vol":"1.62"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.84","vol":"1.58"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.34 | - | 0.92 | - | 0.84 |
| 行业 | 1.31 | 0.00 | 1.62 | 0.01 | 1.58 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 8/245 ， 24/245。
[{"date":"2026-06-30","value":"1.76","vol":"5.78"},{"date":"2026-03-31","value":"1.88","vol":"6.17"},{"date":"2025-12-31","value":"1.77","vol":"5.27"},{"date":"2025-09-30","value":"1.71","vol":"5.64"},{"date":"2025-06-30","value":"1.62","vol":"5.45"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.76 | 1.88 | 1.77 | 1.71 | 1.62 |
| 行业 | 5.78 | 6.17 | 5.27 | 5.64 | 5.45 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"1.36","vol":"4.71"},{"date":"2026-03-31","value":"1.44","vol":"5.04"},{"date":"2025-12-31","value":"1.35","vol":"4.13"},{"date":"2025-09-30","value":"1.28","vol":"4.49"},{"date":"2025-06-30","value":"1.18","vol":"4.34"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.36 | 1.44 | 1.35 | 1.28 | 1.18 |
| 行业 | 4.71 | 5.04 | 4.13 | 4.49 | 4.34 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 42/245 ， 43/245。
[{"date":"2026-06-30","value":"26.79","vol":"23.17"},{"date":"2026-03-31","value":"24.83","vol":"22.26"},{"date":"2025-12-31","value":"27.10","vol":"23.19"},{"date":"2025-09-30","value":"28.00","vol":"22.23"},{"date":"2025-06-30","value":"29.06","vol":"22.18"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
26.79 | 24.83 | 27.10 | 28.00 | 29.06 |
| 行业(%) | 23.17 | 22.26 | 23.19 | 22.23 | 22.18 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.40","vol":"0.42"},{"date":"2026-03-31","value":"0.37","vol":"0.40"},{"date":"2025-12-31","value":"0.42","vol":"0.41"},{"date":"2025-09-30","value":"0.45","vol":"0.72"},{"date":"2025-06-30","value":"0.47","vol":"0.58"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.40 | 0.37 | 0.42 | 0.45 | 0.47 |
| 行业(%) | 0.42 | 0.40 | 0.41 | 0.72 | 0.58 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"3.12","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.31","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"2.15","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"2.40","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]